MOUHAMED AL SHEIKHA: Open Payments
NPI 1063418374 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 21 payments from 12 companies in 2025. Trend: 2023 $293 · 2024 $349 · 2025 $500
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| ABBVIE INC. | 2 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Travere Therapeutics, Inc. | 2 | $54 |
| Ardelyx, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Fabhalta, EMBLAVEO, Kerendia, IBSRELA, GATTEX, JYNARQUE, TAVNEOS, FARXIGA.
Industry payments across IA — which companies pay providers there.
